Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2017 17:15 ET | Source: Enzymotec Ltd.

Enzymotec Shareholders Approve Proposed Acquisition by Frutarom

MIGDAL HA’EMEQ, Israel, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid...
November 15, 2017 07:35 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports Third Quarter 2017 Unaudited Financial Results

MIGDAL HA’EMEQ, Israel, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional products,...
November 02, 2017 08:15 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Calls 2017 Annual and Extraordinary General Meeting of Shareholders for Approval of Merger and Other Matters

MIGDAL HA’EMEQ, Israel, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY) (the “Company”), today announced that it will hold its 2017 Annual and Extraordinary General Meeting of...
October 29, 2017 00:00 ET | Source: Enzymotec Ltd.

Enzymotec Enters Definitive Agreement to be Acquired by Frutarom

MIGDAL HA’EMEQ, Israel, Oct. 29, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional products,...
August 30, 2017 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Expands VAYA Product Portfolio with Five Nutritional Supplements Acquired from Union Springs Healthcare

MIGDAL HA'EMEQ, Israel, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional...
August 28, 2017 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Responds to Unsolicited Proposal from Frutarom Ltd.

MIGDAL HA’EMEQ, Israel, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) today responded to the unsolicited proposal from Frutarom Ltd. to acquire Enzymotec for $11.50 per share by...
August 16, 2017 07:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports Second Quarter 2017 Unaudited Financial Results

Record INFAT® Net Revenues of $13.3 Million (Proportionate Consolidation Method) Generated Strong Cash Flow from Operations of $2.9 Million Inventory Write-Off of $3.3 Million MIGDAL HA'EMEQ,...
July 28, 2017 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Appointment of Dror Israel as Chief Financial Officer

MIGDAL HA'EMEQ, Israel, July 28, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid based...
July 26, 2017 08:30 ET | Source: Enzymotec Ltd.

Enzymotec to Report Second Quarter 2017 Financial Results

MIGDAL HA'EMEQ, Israel, July 26, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid...
June 28, 2017 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Chief Financial Officer to Step Down

MIGDAL HA'EMEQ, Israel, June 28, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid...